Senior Vice President and General Manager, Human Nutrition and Health · BALCHEM CORP (BCPC)

Frederic Boned

A named executive officer of BALCHEM in every fiscal year CompBrief holds from FY2023 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$2,252,491

Salary $542,265Stock awards $752,927

FY2024: $1,882,090

4th of 5 named executive officers at Balchem by FY2025 total.

5 named officers on file for BALCHEM, FY2025

Frederic Boned’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • BCPC’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BALCHEM’s whole pay program stands against its peers

  • BALCHEM’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BCPC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2026 (DEF 14A).

Free

Get Frederic Boned’s full pay file as a PDF — free

More than this page: up to 10 years of Frederic’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Frederic Boned compensation by year

BALCHEM Summary Compensation Table · all 3 fiscal years held
In US dollars, as BALCHEM reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024FY2025
Salary$432,765$518,125$542,265
Bonus$50,000$0$0
Stock awards$319,662$593,513$752,927
Option awards$106,345$200,353$254,047
Non-equity incentive$198,832$537,999$671,452
Pension and deferred compensation$0$0$0
All other$30,600$32,100$31,800
Total$1,138,204$1,882,090$2,252,491

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BALCHEM CORP DEF 14A filed April 27, 2026, accession 0001140361-26-017099, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BALCHEM CORP filed document, accession 0001140361-26-017099. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

$1.1M
$1.9M
$2.3M
FY23
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU3,180$487,685—
PSU2,440$374,198—
RSU1,580$242,309—
PSU1,420$217,771—
RSU1,380$211,637—
RSU770$118,087—
Option1,040—$138.09
Option3,600—$143.43
Option5,200—$159.18

Per the Outstanding Equity Awards at Fiscal Year-End table in BALCHEM CORP's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

BALCHEM’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Ted HarrisChairman, President and Chief Executive Officer$7,894,874
C. Martin BengtssonExecutive Vice President and Chief Financial Officer$2,974,897
Hatsuki MiyataExecutive Vice President, Chief Legal Officer and Secretary$2,392,365
Frederic Boned · this pageSenior Vice President and General Manager, Human Nutrition and Health$2,252,491
M. Brent TignorSenior Vice President and Chief Human Resources Officer$1,780,641

The full BALCHEM compensation record

free company brief

This page is one person within BALCHEM's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BALCHEM proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BALCHEM's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Frederic Boned's compensation dossier · One-time report. No refunds.